SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Arlington Financial Advisors LLC

Arlington Financial Advisors LLC lowered its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 48.5% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 22,504 shares of the exchange traded fund’s stock after selling 21,216 shares during the period. Arlington Financial Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $2,027,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. Golden State Wealth Management LLC purchased a new position in shares of SPDR S&P Biotech ETF in the 4th quarter valued at about $29,000. Avior Wealth Management LLC boosted its position in SPDR S&P Biotech ETF by 393.6% during the fourth quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock worth $35,000 after purchasing an additional 307 shares in the last quarter. Tidemark LLC grew its holdings in SPDR S&P Biotech ETF by 101.5% in the third quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock valued at $39,000 after purchasing an additional 199 shares during the period. Quintet Private Bank Europe S.A. purchased a new stake in shares of SPDR S&P Biotech ETF in the third quarter valued at approximately $40,000. Finally, ORG Wealth Partners LLC acquired a new position in shares of SPDR S&P Biotech ETF during the 3rd quarter worth approximately $44,000.

SPDR S&P Biotech ETF Price Performance

Shares of NYSEARCA:XBI opened at $91.24 on Friday. The business’s 50 day moving average price is $92.58 and its 200-day moving average price is $96.50. SPDR S&P Biotech ETF has a 1 year low of $81.14 and a 1 year high of $105.47. The firm has a market capitalization of $6.95 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.